Lakefront Biotherapeutics N.V.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Lakefront Biotherapeutics N.V. is publicly traded on NASDAQ under the ticker LKFT.
Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential...
Can you invest in Lakefront Biotherapeutics N.V.?
Yes. Lakefront Biotherapeutics N.V. trades publicly on NASDAQ as LKFT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Lakefront Biotherapeutics N.V.
Detailed equity research is provided by MarketSnap.